Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

PMN US Equity

ProMIS Neurosciences Inc.Health Care · Pharmaceutical Preparations · CIK 1374339 · FY ends Dec 31
$14.66
-0.32 (-2.14%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by GREAT POINT PARTNERS LLCsec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Wellington Biomedical Innovation Master Investors (Cayman) II L.P.sec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLPsec.gov ↗
2026-07-288-K 8.01Other eventssec.gov ↗
2026-07-288-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-28

Every row is a filed document, checked against its EDGAR index.